In Brief: OTC emergency eyewash meeting, FDA official to Perrigo, e-cigarette regulation urged, emerging markets key for J&J in OTC
This article was originally published in The Tan Sheet
FDA seeks OTC emergency eyewash input; CDER office head moves to Perrigo; Lawmakers, medical groups urge e-cigarette regulation; J&J eyes emerging markets for OTC business; more news In Brief.
You may also be interested in...
Outgoing Office of New Drugs director dismisses speculation that his decision to leave the agency was related to events surrounding Sarepta's controversial Exondys 51 approval.
Johnson & Johnson CEO Alex Gorsky says bringing recalled OTCs such as Tylenol and Motrin products back to market is the firm’s “clear number one priority” in the near term. J&J also has a timetable for completing its responsibilities under a consent decree with FDA in place since 2011.